NEW YORK (Reuters Health) - Back pain, migraine and other types of chronic pain without a known physical cause - and therefore little prospect for relief - were associated with an increased risk of suicide in a new study of U.S. veterans.
NEW YORK (Reuters Health) - Despite expert guidelines advising against intense sports activity for people with implanted heart defibrillators, a new study suggests that some can compete without serious consequences.
- The Food and Drug Administration said on Friday it has received seven reports of illnesses in patients who took steroid injections compounded by a pharmacy in Tennessee.
GENEVA - The World Health Organization (WHO) said on Friday that it would help Saudi Arabia dig deeper into deadly outbreaks of a new SARS-like virus to draw up advice ahead of the annual haj pilgrimage, which attracts millions of Muslims.
HONG KONG - The new H7N9 bird flu virus can be transmitted between mammals not only via direct contact but also in airborne droplets, and may be capable of spreading from person to person, Chinese and American researchers have found. | Video
NEW YORK - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a person familiar with the matter said on Friday.
WASHINGTON - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory authority over drug compounding.
NEW BRUNSWICK, New Jersey - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a treatment for patients with depression who have failed to benefit from standard medications.
COPENHAGEN - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential.